CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting target hepatitis B virus-positive cells

Front Immunol. 2024 Apr 22:15:1340619. doi: 10.3389/fimmu.2024.1340619. eCollection 2024.

Abstract

To design new CARs targeting hepatitis B virus (HBV), we isolated human monoclonal antibodies recognizing the HBV envelope proteins from single B cells of a patient with a resolved infection. HBV-specific memory B cells were isolated by incubating peripheral blood mononuclear cells with biotinylated hepatitis B surface antigen (HBsAg), followed by single-cell flow cytometry-based sorting of live, CD19+ IgG+ HBsAg+ cells. Amplification and sequencing of immunoglobulin genes from single memory B cells identified variable heavy and light chain sequences. Corresponding immunoglobulin chains were cloned into IgG1 expression vectors and expressed in mammalian cells. Two antibodies named 4D06 and 4D08 were found to be highly specific for HBsAg, recognized a conformational and a linear epitope, respectively, and showed broad reactivity and neutralization capacity against all major HBV genotypes. 4D06 and 4D08 variable chain fragments were cloned into a 2nd generation CAR format with CD28 and CD3zeta intracellular signaling domains. The new CAR constructs displayed a high functional avidity when expressed on primary human T cells. CAR-grafted T cells proved to be polyfunctional regarding cytokine secretion and killed HBV-positive target cells. Interestingly, background activation of the 4D08-CAR recognizing a linear instead of a conformational epitope was consistently low. In a preclinical model of chronic HBV infection, murine T cells grafted with the 4D06 and the 4D08 CAR showed on target activity indicated by a transient increase in serum transaminases, and a lower number of HBV-positive hepatocytes in the mice treated. This study demonstrates an efficient and fast approach to identifying pathogen-specific monoclonal human antibodies from small donor cell numbers for the subsequent generation of new CARs.

Keywords: HBsAg; broad neutralization; chimeric antigen receptor; hepatitis B virus envelope proteins; human monoclonal antibody; linear epitope; single B cell sorting; tonic signaling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / immunology
  • B-Lymphocytes / immunology
  • Broadly Neutralizing Antibodies / immunology
  • Hepatitis B / immunology
  • Hepatitis B / virology
  • Hepatitis B Surface Antigens* / immunology
  • Hepatitis B virus* / genetics
  • Hepatitis B virus* / immunology
  • Humans
  • Immunotherapy, Adoptive
  • Mice
  • Receptors, Chimeric Antigen / genetics
  • Receptors, Chimeric Antigen / immunology
  • Receptors, Chimeric Antigen / metabolism
  • T-Lymphocytes / immunology

Substances

  • Hepatitis B Surface Antigens
  • Receptors, Chimeric Antigen
  • Antibodies, Monoclonal
  • Broadly Neutralizing Antibodies

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the German Research Foundation (DFG) via SFB-TRR 338/1, project No. 452881907 to UP and via SFB-TRR179 SFB-TRR 179/2, project No. 2983813 to SU, UP and Carolin Mogler supporting TG, by the German Center for Infection Research (DZIF), TTU Hepatitis project 05.806 to UP and SU, and by a research grant from SCG Cell Therapy Pte Ltd. SCG Cell Therapy Pte Ltd was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication. All authors declare no other competing interests.